img

Global and United States Liposomes Nanocarrier Drug Market Report & Forecast 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and United States Liposomes Nanocarrier Drug Market Report & Forecast 2024-2034

Nanoparticle drug delivery systems are engineered technologies that use nanoparticles for the targeted delivery and controlled release of therapeutic agents. The modern form of a drug delivery system should minimize side-effects and reduce both dosage and dosage frequency. Recently, nanoparticles have aroused attention due to their potential application for effective drug delivery.
Market Analysis and InsightsGlobal and United States Liposomes Nanocarrier Drug Market
This report focuses on global and United States Liposomes Nanocarrier Drug market, also covers the segmentation data of other regions in regional level and county level.
The global Liposomes Nanocarrier Drug revenue was US$ 4851 million in 2022 and is forecast to a readjusted size of US$ 10840 million by 2029 with a CAGR of 12.2% during the review period (2024-2034).
In United States the Liposomes Nanocarrier Drug revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period 2024-2034.
The global key players of Liposomes Nanocarrier Drug include Johnson & Johnson, Sun Pharmaceutical, CSPC, Kinyond, Teva, Fudan-Zhangjiang, Zydus Cadila, TTY Biopharma and Pacira, etc. The global five biggest players hold a share of % in 2022.
Global Liposomes Nanocarrier Drug Scope and Market Size
Liposomes Nanocarrier Drug market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Liposomes Nanocarrier Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2029.
For United States market, this report focuses on the Liposomes Nanocarrier Drug market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in United States.



By Company


Johnson & Johnson
Sun Pharmaceutical
CSPC
Kinyond
Teva
Fudan-Zhangjiang
Zydus Cadila
TTY Biopharma
Pacira
Luye Pharma
Leadiant Biosciences
Ipsen
Sayre Therapeutics
Jazz
Alnylam
Bausch Health
Acrotech Biopharma
Takeda
Chiesi Farmaceutici
Gilead Sciences
Segment by Type
Liposomes Drugs
Lipid Nanoparticle Drugs

Segment by Application


Hospital
Retail Pharmacy
Other
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Liposomes Nanocarrier Drug definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Liposomes Nanocarrier Drug companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Liposomes Nanocarrier Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liposomes Nanocarrier Drug revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions

Table of Content

1 Study Coverage
1.1 Liposomes Nanocarrier Drug Product Introduction
1.2 Global Liposomes Nanocarrier Drug Outlook 2018 VS 2022 VS 2029
1.2.1 Global Liposomes Nanocarrier Drug Market Size for the Year 2018-2029
1.2.2 United States Liposomes Nanocarrier Drug Market Size for the Year 2018-2029
1.3 Liposomes Nanocarrier Drug Market Size, United States VS Global, 2018 VS 2022 VS 2029
1.3.1 The Market Share of United States Liposomes Nanocarrier Drug in Global, 2018 VS 2022 VS 2029
1.3.2 The Growth Rate of Liposomes Nanocarrier Drug Market Size, United States VS Global, 2018 VS 2022 VS 2029
1.4 Liposomes Nanocarrier Drug Market Dynamics
1.4.1 Liposomes Nanocarrier Drug Industry Trends
1.4.2 Liposomes Nanocarrier Drug Market Drivers
1.4.3 Liposomes Nanocarrier Drug Market Challenges
1.4.4 Liposomes Nanocarrier Drug Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Liposomes Nanocarrier Drug by Type
2.1 Liposomes Nanocarrier Drug Market Segment by Type
2.1.1 Liposomes Drugs
2.1.2 Lipid Nanoparticle Drugs
2.2 Global Liposomes Nanocarrier Drug Market Size by Type (2018, 2022 & 2029)
2.3 Global Liposomes Nanocarrier Drug Market Size by Type (2018-2029)
2.4 United States Liposomes Nanocarrier Drug Market Size by Type (2018, 2022 & 2029)
2.5 United States Liposomes Nanocarrier Drug Market Size by Type (2018-2029)
3 Liposomes Nanocarrier Drug by Application
3.1 Liposomes Nanocarrier Drug Market Segment by Application
3.1.1 Hospital
3.1.2 Retail Pharmacy
3.1.3 Other
3.2 Global Liposomes Nanocarrier Drug Market Size by Application (2018, 2022 & 2029)
3.3 Global Liposomes Nanocarrier Drug Market Size by Application (2018-2029)
3.4 United States Liposomes Nanocarrier Drug Market Size by Application (2018, 2022 & 2029)
3.5 United States Liposomes Nanocarrier Drug Market Size by Application (2018-2029)
4 Global Liposomes Nanocarrier Drug Competitor Landscape by Company
4.1 Global Liposomes Nanocarrier Drug Market Size by Company
4.1.1 Global Key Companies of Liposomes Nanocarrier Drug, Ranked by Revenue (2022)
4.1.2 Global Liposomes Nanocarrier Drug Revenue by Player (2018-2024)
4.2 Global Liposomes Nanocarrier Drug Concentration Ratio (CR)
4.2.1 Liposomes Nanocarrier Drug Market Concentration Ratio (CR) (2018-2024)
4.2.2 Global Top 5 and Top 10 Largest Companies of Liposomes Nanocarrier Drug in 2022
4.2.3 Global Liposomes Nanocarrier Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Liposomes Nanocarrier Drug Head office and Area Served
4.4 Global Key Players of Liposomes Nanocarrier Drug, Product and Application
4.5 Global Key Players of Liposomes Nanocarrier Drug, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States Liposomes Nanocarrier Drug Market Size by Company
4.7.1 Key Players of Liposomes Nanocarrier Drug in United States, Ranked by Revenue (2022)
4.7.2 United States Liposomes Nanocarrier Drug Revenue by Players (2021, 2022 & 2024)
5 Global Liposomes Nanocarrier Drug Market Size by Region
5.1 Global Liposomes Nanocarrier Drug Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Liposomes Nanocarrier Drug Market Size by Region (2018-2029)
5.2.1 Global Liposomes Nanocarrier Drug Market Size by Region: 2018-2024
5.2.2 Global Liposomes Nanocarrier Drug Market Size by Region (2024-2029)
6 Americas
6.1 Americas Liposomes Nanocarrier Drug Market Size YoY Growth 2018-2029
6.2 Americas Liposomes Nanocarrier Drug Market Size by Type
6.2.1 Americas Liposomes Nanocarrier Drug Market Size by Type (2018-2024)
6.2.2 Americas Liposomes Nanocarrier Drug Market Size by Type (2024-2029)
6.2.3 Americas Liposomes Nanocarrier Drug Market Share by Type (2018-2029)
6.3 Americas Liposomes Nanocarrier Drug Market Size by Application
6.3.1 Americas Liposomes Nanocarrier Drug Market Size by Application (2018-2024)
6.3.2 Americas Liposomes Nanocarrier Drug Market Size by Application (2024-2029)
6.3.3 Americas Liposomes Nanocarrier Drug Market Share by Application (2018-2029)
6.4 Americas Liposomes Nanocarrier Drug Market Facts & Figures by Country (2018, 2022 & 2029)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Liposomes Nanocarrier Drug Market Size YoY Growth 2018-2029
7.2 EMEA Liposomes Nanocarrier Drug Market Size by Type
7.2.1 EMEA Liposomes Nanocarrier Drug Market Size by Type (2018-2024)
7.2.2 EMEA Liposomes Nanocarrier Drug Market Size by Type (2024-2029)
7.2.3 EMEA Liposomes Nanocarrier Drug Market Share by Type (2018-2029)
7.3 EMEA Liposomes Nanocarrier Drug Market Size by Application
7.3.1 EMEA Liposomes Nanocarrier Drug Market Size by Application (2018-2024)
7.3.2 EMEA Liposomes Nanocarrier Drug Market Size by Application (2024-2029)
7.3.3 EMEA Liposomes Nanocarrier Drug Market Share by Application (2018-2029)
7.4 EMEA Liposomes Nanocarrier Drug Market Facts & Figures by Country (2018, 2022 & 2029)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Liposomes Nanocarrier Drug Market Size YoY Growth 2018-2029
8.2 China Liposomes Nanocarrier Drug Market Size by Type
8.2.1 China Liposomes Nanocarrier Drug Market Size by Type (2018-2024)
8.2.2 China Liposomes Nanocarrier Drug Market Size by Type (2024-2029)
8.2.3 China Liposomes Nanocarrier Drug Market Share by Type (2018-2029)
8.3 China Liposomes Nanocarrier Drug Market Size by Application
8.3.1 China Liposomes Nanocarrier Drug Market Size by Application (2018-2024)
8.3.2 China Liposomes Nanocarrier Drug Market Size by Application (2024-2029)
8.3.3 China Liposomes Nanocarrier Drug Market Share by Application (2018-2029)
9 APAC (excluding China)
9.1 APAC Liposomes Nanocarrier Drug Market Size YoY Growth 2018-2029
9.2 APAC Liposomes Nanocarrier Drug Market Size by Type
9.2.1 APAC Liposomes Nanocarrier Drug Market Size by Type (2018-2024)
9.2.2 APAC Liposomes Nanocarrier Drug Market Size by Type (2024-2029)
9.2.3 APAC Liposomes Nanocarrier Drug Market Share by Type (2018-2029)
9.3 APAC Liposomes Nanocarrier Drug Market Size by Application
9.3.1 APAC Liposomes Nanocarrier Drug Market Size by Application (2018-2024)
9.3.2 APAC Liposomes Nanocarrier Drug Market Size by Application (2024-2029)
9.3.3 APAC Liposomes Nanocarrier Drug Market Share by Application (2018-2029)
9.4 APAC Liposomes Nanocarrier Drug Market Facts & Figures by Country (2018, 2022 & 2029)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Johnson & Johnson
10.1.1 Johnson & Johnson Company Details
10.1.2 Johnson & Johnson Business Overview
10.1.3 Johnson & Johnson Liposomes Nanocarrier Drug Introduction
10.1.4 Johnson & Johnson Revenue in Liposomes Nanocarrier Drug Business (2018-2024)
10.1.5 Johnson & Johnson Recent Development
10.2 Sun Pharmaceutical
10.2.1 Sun Pharmaceutical Company Details
10.2.2 Sun Pharmaceutical Business Overview
10.2.3 Sun Pharmaceutical Liposomes Nanocarrier Drug Introduction
10.2.4 Sun Pharmaceutical Revenue in Liposomes Nanocarrier Drug Business (2018-2024)
10.2.5 Sun Pharmaceutical Recent Development
10.3 CSPC
10.3.1 CSPC Company Details
10.3.2 CSPC Business Overview
10.3.3 CSPC Liposomes Nanocarrier Drug Introduction
10.3.4 CSPC Revenue in Liposomes Nanocarrier Drug Business (2018-2024)
10.3.5 CSPC Recent Development
10.4 Kinyond
10.4.1 Kinyond Company Details
10.4.2 Kinyond Business Overview
10.4.3 Kinyond Liposomes Nanocarrier Drug Introduction
10.4.4 Kinyond Revenue in Liposomes Nanocarrier Drug Business (2018-2024)
10.4.5 Kinyond Recent Development
10.5 Teva
10.5.1 Teva Company Details
10.5.2 Teva Business Overview
10.5.3 Teva Liposomes Nanocarrier Drug Introduction
10.5.4 Teva Revenue in Liposomes Nanocarrier Drug Business (2018-2024)
10.5.5 Teva Recent Development
10.6 Fudan-Zhangjiang
10.6.1 Fudan-Zhangjiang Company Details
10.6.2 Fudan-Zhangjiang Business Overview
10.6.3 Fudan-Zhangjiang Liposomes Nanocarrier Drug Introduction
10.6.4 Fudan-Zhangjiang Revenue in Liposomes Nanocarrier Drug Business (2018-2024)
10.6.5 Fudan-Zhangjiang Recent Development
10.7 Zydus Cadila
10.7.1 Zydus Cadila Company Details
10.7.2 Zydus Cadila Business Overview
10.7.3 Zydus Cadila Liposomes Nanocarrier Drug Introduction
10.7.4 Zydus Cadila Revenue in Liposomes Nanocarrier Drug Business (2018-2024)
10.7.5 Zydus Cadila Recent Development
10.8 TTY Biopharma
10.8.1 TTY Biopharma Company Details
10.8.2 TTY Biopharma Business Overview
10.8.3 TTY Biopharma Liposomes Nanocarrier Drug Introduction
10.8.4 TTY Biopharma Revenue in Liposomes Nanocarrier Drug Business (2018-2024)
10.8.5 TTY Biopharma Recent Development
10.9 Pacira
10.9.1 Pacira Company Details
10.9.2 Pacira Business Overview
10.9.3 Pacira Liposomes Nanocarrier Drug Introduction
10.9.4 Pacira Revenue in Liposomes Nanocarrier Drug Business (2018-2024)
10.9.5 Pacira Recent Development
10.10 Luye Pharma
10.10.1 Luye Pharma Company Details
10.10.2 Luye Pharma Business Overview
10.10.3 Luye Pharma Liposomes Nanocarrier Drug Introduction
10.10.4 Luye Pharma Revenue in Liposomes Nanocarrier Drug Business (2018-2024)
10.10.5 Luye Pharma Recent Development
10.11 Leadiant Biosciences
10.11.1 Leadiant Biosciences Company Details
10.11.2 Leadiant Biosciences Business Overview
10.11.3 Leadiant Biosciences Liposomes Nanocarrier Drug Introduction
10.11.4 Leadiant Biosciences Revenue in Liposomes Nanocarrier Drug Business (2018-2024)
10.11.5 Leadiant Biosciences Recent Development
10.12 Ipsen
10.12.1 Ipsen Company Details
10.12.2 Ipsen Business Overview
10.12.3 Ipsen Liposomes Nanocarrier Drug Introduction
10.12.4 Ipsen Revenue in Liposomes Nanocarrier Drug Business (2018-2024)
10.12.5 Ipsen Recent Development
10.13 Sayre Therapeutics
10.13.1 Sayre Therapeutics Company Details
10.13.2 Sayre Therapeutics Business Overview
10.13.3 Sayre Therapeutics Liposomes Nanocarrier Drug Introduction
10.13.4 Sayre Therapeutics Revenue in Liposomes Nanocarrier Drug Business (2018-2024)
10.13.5 Sayre Therapeutics Recent Development
10.14 Jazz
10.14.1 Jazz Company Details
10.14.2 Jazz Business Overview
10.14.3 Jazz Liposomes Nanocarrier Drug Introduction
10.14.4 Jazz Revenue in Liposomes Nanocarrier Drug Business (2018-2024)
10.14.5 Jazz Recent Development
10.15 Alnylam
10.15.1 Alnylam Company Details
10.15.2 Alnylam Business Overview
10.15.3 Alnylam Liposomes Nanocarrier Drug Introduction
10.15.4 Alnylam Revenue in Liposomes Nanocarrier Drug Business (2018-2024)
10.15.5 Alnylam Recent Development
10.16 Bausch Health
10.16.1 Bausch Health Company Details
10.16.2 Bausch Health Business Overview
10.16.3 Bausch Health Liposomes Nanocarrier Drug Introduction
10.16.4 Bausch Health Revenue in Liposomes Nanocarrier Drug Business (2018-2024)
10.16.5 Bausch Health Recent Development
10.17 Acrotech Biopharma
10.17.1 Acrotech Biopharma Company Details
10.17.2 Acrotech Biopharma Business Overview
10.17.3 Acrotech Biopharma Liposomes Nanocarrier Drug Introduction
10.17.4 Acrotech Biopharma Revenue in Liposomes Nanocarrier Drug Business (2018-2024)
10.17.5 Acrotech Biopharma Recent Development
10.18 Takeda
10.18.1 Takeda Company Details
10.18.2 Takeda Business Overview
10.18.3 Takeda Liposomes Nanocarrier Drug Introduction
10.18.4 Takeda Revenue in Liposomes Nanocarrier Drug Business (2018-2024)
10.18.5 Takeda Recent Development
10.19 Chiesi Farmaceutici
10.19.1 Chiesi Farmaceutici Company Details
10.19.2 Chiesi Farmaceutici Business Overview
10.19.3 Chiesi Farmaceutici Liposomes Nanocarrier Drug Introduction
10.19.4 Chiesi Farmaceutici Revenue in Liposomes Nanocarrier Drug Business (2018-2024)
10.19.5 Chiesi Farmaceutici Recent Development
10.20 Gilead Sciences
10.20.1 Gilead Sciences Company Details
10.20.2 Gilead Sciences Business Overview
10.20.3 Gilead Sciences Liposomes Nanocarrier Drug Introduction
10.20.4 Gilead Sciences Revenue in Liposomes Nanocarrier Drug Business (2018-2024)
10.20.5 Gilead Sciences Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. Liposomes Nanocarrier Drug Market Size United States VS Global, CAGR (2018 VS 2022 VS 2029)
Table 2. Liposomes Nanocarrier Drug Market Trends
Table 3. Liposomes Nanocarrier Drug Market Drivers
Table 4. Liposomes Nanocarrier Drug Market Challenges
Table 5. Liposomes Nanocarrier Drug Market Restraints
Table 6. Global Liposomes Nanocarrier Drug Market Size by Type: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. United States Liposomes Nanocarrier Drug Market Size by Type: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Liposomes Nanocarrier Drug Market Size by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 9. United States Liposomes Nanocarrier Drug Market Size by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 10. Global Key Companies of Liposomes Nanocarrier Drug, Ranked by Revenue (2022) & (US$ Million)
Table 11. Global Liposomes Nanocarrier Drug Revenue by Player, (US$ Million), 2018-2024
Table 12. Global Liposomes Nanocarrier Drug Revenue Share by Player, 2018-2024
Table 13. Global Liposomes Nanocarrier Drug Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Liposomes Nanocarrier Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposomes Nanocarrier Drug as of 2022)
Table 15. Global Key Players of Liposomes Nanocarrier Drug, Headquarters and Area Served
Table 16. Global Key Players of Liposomes Nanocarrier Drug, Product and Application
Table 17. Global Key Players of Liposomes Nanocarrier Drug, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of Liposomes Nanocarrier Drug in United States, Ranked by Revenue (2022) & (US$ Million)
Table 20. United States Liposomes Nanocarrier Drug Revenue by Players, (US$ Million), 2021, 2022 & 2024
Table 21. United States Liposomes Nanocarrier Drug Revenue Share by Players, 2021, 2022 & 2024
Table 22. Global Liposomes Nanocarrier Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 23. Global Liposomes Nanocarrier Drug Market Size by Region (2018-2024) & (US$ Million)
Table 24. Global Liposomes Nanocarrier Drug Market Size Forecast by Region (2024-2029) & (US$ Million)
Table 25. Americas Liposomes Nanocarrier Drug Market Size by Type (2018-2024) & (US$ Million)
Table 26. Americas Liposomes Nanocarrier Drug Market Size by Type (2024-2029) & (US$ Million)
Table 27. Americas Liposomes Nanocarrier Drug Market Size by Application (2018-2024) & (US$ Million)
Table 28. Americas Liposomes Nanocarrier Drug Market Size by Application (2024-2029) & (US$ Million)
Table 29. Americas Liposomes Nanocarrier Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 30. Americas Liposomes Nanocarrier Drug Market Size by Country (2018-2024) & (US$ Million)
Table 31. Americas Liposomes Nanocarrier Drug Market Size by Country (2024-2029) & (US$ Million)
Table 32. EMEA Liposomes Nanocarrier Drug Market Size by Type (2018-2024) & (US$ Million)
Table 33. EMEA Liposomes Nanocarrier Drug Market Size by Type (2024-2029) & (US$ Million)
Table 34. EMEA Liposomes Nanocarrier Drug Market Size by Application (2018-2024) & (US$ Million)
Table 35. EMEA Liposomes Nanocarrier Drug Market Size by Application (2024-2029) & (US$ Million)
Table 36. EMEA Liposomes Nanocarrier Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. EMEA Liposomes Nanocarrier Drug Market Size by Country (2018-2024) & (US$ Million)
Table 38. EMEA Liposomes Nanocarrier Drug Market Size by Country (2024-2029) & (US$ Million)
Table 39. China Liposomes Nanocarrier Drug Market Size by Type (2018-2024) & (US$ Million)
Table 40. China Liposomes Nanocarrier Drug Market Size by Type (2024-2029) & (US$ Million)
Table 41. China Liposomes Nanocarrier Drug Market Size by Application (2018-2024) & (US$ Million)
Table 42. China Liposomes Nanocarrier Drug Market Size by Application (2024-2029) & (US$ Million)
Table 43. China Liposomes Nanocarrier Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. APAC Liposomes Nanocarrier Drug Market Size by Type (2018-2024) & (US$ Million)
Table 45. APAC Liposomes Nanocarrier Drug Market Size by Type (2024-2029) & (US$ Million)
Table 46. APAC Liposomes Nanocarrier Drug Market Size by Application (2018-2024) & (US$ Million)
Table 47. APAC Liposomes Nanocarrier Drug Market Size by Application (2024-2029) & (US$ Million)
Table 48. APAC Liposomes Nanocarrier Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 49. APAC Liposomes Nanocarrier Drug Market Size by Region (2018-2024) & (US$ Million)
Table 50. APAC Liposomes Nanocarrier Drug Market Size by Region (2024-2029) & (US$ Million)
Table 51. Johnson & Johnson Company Details
Table 52. Johnson & Johnson Business Overview
Table 53. Johnson & Johnson Liposomes Nanocarrier Drug Product
Table 54. Johnson & Johnson Revenue in Liposomes Nanocarrier Drug Business (2018-2024) & (US$ Million)
Table 55. Johnson & Johnson Recent Development
Table 56. Sun Pharmaceutical Company Details
Table 57. Sun Pharmaceutical Business Overview
Table 58. Sun Pharmaceutical Liposomes Nanocarrier Drug Product
Table 59. Sun Pharmaceutical Revenue in Liposomes Nanocarrier Drug Business (2018-2024) & (US$ Million)
Table 60. Sun Pharmaceutical Recent Development
Table 61. CSPC Company Details
Table 62. CSPC Business Overview
Table 63. CSPC Liposomes Nanocarrier Drug Product
Table 64. CSPC Revenue in Liposomes Nanocarrier Drug Business (2018-2024) & (US$ Million)
Table 65. CSPC Recent Development
Table 66. Kinyond Company Details
Table 67. Kinyond Business Overview
Table 68. Kinyond Liposomes Nanocarrier Drug Product
Table 69. Kinyond Revenue in Liposomes Nanocarrier Drug Business (2018-2024) & (US$ Million)
Table 70. Kinyond Recent Development
Table 71. Teva Company Details
Table 72. Teva Business Overview
Table 73. Teva Liposomes Nanocarrier Drug Product
Table 74. Teva Revenue in Liposomes Nanocarrier Drug Business (2018-2024) & (US$ Million)
Table 75. Teva Recent Development
Table 76. Fudan-Zhangjiang Company Details
Table 77. Fudan-Zhangjiang Business Overview
Table 78. Fudan-Zhangjiang Liposomes Nanocarrier Drug Product
Table 79. Fudan-Zhangjiang Revenue in Liposomes Nanocarrier Drug Business (2018-2024) & (US$ Million)
Table 80. Fudan-Zhangjiang Recent Development
Table 81. Zydus Cadila Company Details
Table 82. Zydus Cadila Business Overview
Table 83. Zydus Cadila Liposomes Nanocarrier Drug Product
Table 84. Zydus Cadila Revenue in Liposomes Nanocarrier Drug Business (2018-2024) & (US$ Million)
Table 85. Zydus Cadila Recent Development
Table 86. TTY Biopharma Company Details
Table 87. TTY Biopharma Business Overview
Table 88. TTY Biopharma Liposomes Nanocarrier Drug Product
Table 89. TTY Biopharma Revenue in Liposomes Nanocarrier Drug Business (2018-2024) & (US$ Million)
Table 90. TTY Biopharma Recent Development
Table 91. Pacira Company Details
Table 92. Pacira Business Overview
Table 93. Pacira Liposomes Nanocarrier Drug Product
Table 94. Pacira Revenue in Liposomes Nanocarrier Drug Business (2018-2024) & (US$ Million)
Table 95. Pacira Recent Development
Table 96. Luye Pharma Company Details
Table 97. Luye Pharma Business Overview
Table 98. Luye Pharma Liposomes Nanocarrier Drug Product
Table 99. Luye Pharma Revenue in Liposomes Nanocarrier Drug Business (2018-2024) & (US$ Million)
Table 100. Luye Pharma Recent Development
Table 101. Leadiant Biosciences Company Details
Table 102. Leadiant Biosciences Business Overview
Table 103. Leadiant Biosciences Liposomes Nanocarrier Drug Product
Table 104. Leadiant Biosciences Revenue in Liposomes Nanocarrier Drug Business (2018-2024) & (US$ Million)
Table 105. Leadiant Biosciences Recent Development
Table 106. Ipsen Company Details
Table 107. Ipsen Business Overview
Table 108. Ipsen Liposomes Nanocarrier Drug Product
Table 109. Ipsen Revenue in Liposomes Nanocarrier Drug Business (2018-2024) & (US$ Million)
Table 110. Ipsen Recent Development
Table 111. Sayre Therapeutics Company Details
Table 112. Sayre Therapeutics Business Overview
Table 113. Sayre Therapeutics Liposomes Nanocarrier Drug Product
Table 114. Sayre Therapeutics Revenue in Liposomes Nanocarrier Drug Business (2018-2024) & (US$ Million)
Table 115. Sayre Therapeutics Recent Development
Table 116. Jazz Company Details
Table 117. Jazz Business Overview
Table 118. Jazz Liposomes Nanocarrier Drug Product
Table 119. Jazz Revenue in Liposomes Nanocarrier Drug Business (2018-2024) & (US$ Million)
Table 120. Jazz Recent Development
Table 121. Alnylam Company Details
Table 122. Alnylam Business Overview
Table 123. Alnylam Liposomes Nanocarrier Drug Product
Table 124. Alnylam Revenue in Liposomes Nanocarrier Drug Business (2018-2024) & (US$ Million)
Table 125. Alnylam Recent Development
Table 126. Bausch Health Company Details
Table 127. Bausch Health Business Overview
Table 128. Bausch Health Liposomes Nanocarrier Drug Product
Table 129. Bausch Health Revenue in Liposomes Nanocarrier Drug Business (2018-2024) & (US$ Million)
Table 130. Bausch Health Recent Development
Table 131. Acrotech Biopharma Company Details
Table 132. Acrotech Biopharma Business Overview
Table 133. Acrotech Biopharma Liposomes Nanocarrier Drug Product
Table 134. Acrotech Biopharma Revenue in Liposomes Nanocarrier Drug Business (2018-2024) & (US$ Million)
Table 135. Acrotech Biopharma Recent Development
Table 136. Takeda Company Details
Table 137. Takeda Business Overview
Table 138. Takeda Liposomes Nanocarrier Drug Product
Table 139. Takeda Revenue in Liposomes Nanocarrier Drug Business (2018-2024) & (US$ Million)
Table 140. Takeda Recent Development
Table 141. Chiesi Farmaceutici Company Details
Table 142. Chiesi Farmaceutici Business Overview
Table 143. Chiesi Farmaceutici Liposomes Nanocarrier Drug Product
Table 144. Chiesi Farmaceutici Revenue in Liposomes Nanocarrier Drug Business (2018-2024) & (US$ Million)
Table 145. Chiesi Farmaceutici Recent Development
Table 146. Gilead Sciences Company Details
Table 147. Gilead Sciences Business Overview
Table 148. Gilead Sciences Liposomes Nanocarrier Drug Product
Table 149. Gilead Sciences Revenue in Liposomes Nanocarrier Drug Business (2018-2024) & (US$ Million)
Table 150. Gilead Sciences Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Liposomes Nanocarrier Drug Product Picture
Figure 2. Global Liposomes Nanocarrier Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Liposomes Nanocarrier Drug Market Size 2018-2029 (US$ Million)
Figure 4. United States Liposomes Nanocarrier Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 5. United States Liposomes Nanocarrier Drug Market Size 2018-2029 (US$ Million)
Figure 6. United States Liposomes Nanocarrier Drug Market Share in Global 2018-2029
Figure 7. Liposomes Nanocarrier Drug Report Years Considered
Figure 8. Product Picture of Liposomes Drugs
Figure 9. Product Picture of Lipid Nanoparticle Drugs
Figure 10. Global Liposomes Nanocarrier Drug Market Share by Type in 2022 & 2029
Figure 11. Global Liposomes Nanocarrier Drug Market Size by Type (2018-2029) & (US$ Million)
Figure 12. Global Liposomes Nanocarrier Drug Market Share by Type (2018-2029)
Figure 13. United States Liposomes Nanocarrier Drug Market Share by Type in 2022 & 2029
Figure 14. United States Liposomes Nanocarrier Drug Market Size by Type (2018-2029) & (US$ Million)
Figure 15. United States Liposomes Nanocarrier Drug Market Share by Type (2018-2029)
Figure 16. Product Picture of Hospital
Figure 17. Product Picture of Retail Pharmacy
Figure 18. Product Picture of Other
Figure 19. Global Liposomes Nanocarrier Drug Market Share by Application in 2022 & 2029
Figure 20. Global Liposomes Nanocarrier Drug Market Size by Application (2018-2029) & (US$ Million)
Figure 21. Global Liposomes Nanocarrier Drug Market Share by Application (2018-2029)
Figure 22. United States Liposomes Nanocarrier Drug Market Share by Application in 2022 & 2029
Figure 23. United States Liposomes Nanocarrier Drug Market Size by Application (2018-2029) & (US$ Million)
Figure 24. United States Liposomes Nanocarrier Drug Market Share by Application (2018-2029)
Figure 25. The Top 5 and 10 Largest Companies of Liposomes Nanocarrier Drug in the World: Market Share by Liposomes Nanocarrier Drug Revenue in 2022
Figure 26. Global Liposomes Nanocarrier Drug Market Size Market Share by Region: 2018 VS 2022 VS 2029
Figure 27. Global Liposomes Nanocarrier Drug Market Share by Region (2018-2029)
Figure 28. Americas Liposomes Nanocarrier Drug Market Size Growth Rate 2018-2029 (US$ Million)
Figure 29. Americas Liposomes Nanocarrier Drug Market Share by Type (2018-2029)
Figure 30. Americas Liposomes Nanocarrier Drug Market Share by Application (2018-2029)
Figure 31. United States Liposomes Nanocarrier Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 32. Canada Liposomes Nanocarrier Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 33. Mexico Liposomes Nanocarrier Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 34. Brazil Liposomes Nanocarrier Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 35. EMEA Liposomes Nanocarrier Drug Market Size Growth Rate 2018-2029 (US$ Million)
Figure 36. EMEA Liposomes Nanocarrier Drug Market Share by Type (2018-2029)
Figure 37. EMEA Liposomes Nanocarrier Drug Market Share by Application (2018-2029)
Figure 38. Europe Liposomes Nanocarrier Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 39. Middle East Liposomes Nanocarrier Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 40. Africa Liposomes Nanocarrier Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 41. China Liposomes Nanocarrier Drug Market Size Growth Rate 2018-2029 (US$ Million)
Figure 42. China Liposomes Nanocarrier Drug Market Share by Type (2018-2029)
Figure 43. China Liposomes Nanocarrier Drug Market Share by Application (2018-2029)
Figure 44. APAC Liposomes Nanocarrier Drug Market Size Growth Rate 2018-2029 (US$ Million)
Figure 45. APAC Liposomes Nanocarrier Drug Market Share by Type (2018-2029)
Figure 46. APAC Liposomes Nanocarrier Drug Market Share by Application (2018-2029)
Figure 47. Japan Liposomes Nanocarrier Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 48. South Korea Liposomes Nanocarrier Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 49. China Taiwan Liposomes Nanocarrier Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 50. Southeast Asia Liposomes Nanocarrier Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 51. India Liposomes Nanocarrier Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 52. Johnson & Johnson Revenue Growth Rate in Liposomes Nanocarrier Drug Business (2018-2024)
Figure 53. Sun Pharmaceutical Revenue Growth Rate in Liposomes Nanocarrier Drug Business (2018-2024)
Figure 54. CSPC Revenue Growth Rate in Liposomes Nanocarrier Drug Business (2018-2024)
Figure 55. Kinyond Revenue Growth Rate in Liposomes Nanocarrier Drug Business (2018-2024)
Figure 56. Teva Revenue Growth Rate in Liposomes Nanocarrier Drug Business (2018-2024)
Figure 57. Fudan-Zhangjiang Revenue Growth Rate in Liposomes Nanocarrier Drug Business (2018-2024)
Figure 58. Zydus Cadila Revenue Growth Rate in Liposomes Nanocarrier Drug Business (2018-2024)
Figure 59. TTY Biopharma Revenue Growth Rate in Liposomes Nanocarrier Drug Business (2018-2024)
Figure 60. Pacira Revenue Growth Rate in Liposomes Nanocarrier Drug Business (2018-2024)
Figure 61. Luye Pharma Revenue Growth Rate in Liposomes Nanocarrier Drug Business (2018-2024)
Figure 62. Leadiant Biosciences Revenue Growth Rate in Liposomes Nanocarrier Drug Business (2018-2024)
Figure 63. Ipsen Revenue Growth Rate in Liposomes Nanocarrier Drug Business (2018-2024)
Figure 64. Sayre Therapeutics Revenue Growth Rate in Liposomes Nanocarrier Drug Business (2018-2024)
Figure 65. Jazz Revenue Growth Rate in Liposomes Nanocarrier Drug Business (2018-2024)
Figure 66. Alnylam Revenue Growth Rate in Liposomes Nanocarrier Drug Business (2018-2024)
Figure 67. Bausch Health Revenue Growth Rate in Liposomes Nanocarrier Drug Business (2018-2024)
Figure 68. Acrotech Biopharma Revenue Growth Rate in Liposomes Nanocarrier Drug Business (2018-2024)
Figure 69. Takeda Revenue Growth Rate in Liposomes Nanocarrier Drug Business (2018-2024)
Figure 70. Chiesi Farmaceutici Revenue Growth Rate in Liposomes Nanocarrier Drug Business (2018-2024)
Figure 71. Gilead Sciences Revenue Growth Rate in Liposomes Nanocarrier Drug Business (2018-2024)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries